Mr. George Dorin reports

PYNG RECEIVES SECURITYHOLDER APPROVAL FOR ACQUISITION BY TELEFLEX

Pyng Medical Corp.'s previously announced acquisition of all of the issued and outstanding common shares of Pyng by Teleflex Medical Canada Inc., a wholly owned subsidiary of Teleflex Inc., by way of a plan of arrangement, has been approved by the holders of Pyng's shares, options, warrants and convertible debentures. At the special meeting of Pyng securityholders held on March 27, 2017, a special resolution approving the arrangement was approved by 99.97 per cent of the votes cast by the shareholders of Pyng, voting as a single class, present in person or represented by proxy and entitled to vote at the meeting, approved by 99.98 per cent of the votes cast by securityholders, voting as a single class, present in person or represented by proxy and entitled to vote at the meeting, and approved by 99.96 per cent of the votes cast by shareholders of Pyng present in person or represented by proxy and entitled to vote at the meeting, excluding votes cast by those persons whose votes must be excluded pursuant to applicable securities law.

Pursuant to the arrangement, all currently outstanding stock options and warrants will be deemed to be exercised for that number of shares equal to the in-the-money amount of such stock options and warrants in accordance with their terms, and all convertible debentures will be deemed to be converted into shares in accordance with their terms. On closing of the arrangement, each shareholder of Pyng, including holders of stock options, warrants and convertible debentures receiving shares pursuant to the arrangement, will receive cash consideration of 30.203 U.S. cents for each share held.

The arrangement remains subject to final approval from the Supreme Court of British Columbia. The court hearing for the final order to approve the arrangement is scheduled to take place on March 29, 2017, and the completion of the arrangement is expected to occur on April 3, 2017.

Additional information regarding the terms of the arrangement is set out in Pyng's management information circular dated Feb. 20, 2017, which is available under Pyng's profile at SEDAR.

About Pyng Medical Corp.

Based in Richmond, B.C., Pyng Medical commercializes award-winning trauma and resuscitation products for front-line critical care and emergency medical personnel. Pyng's expanded product portfolio includes a variety of innovative, life-saving tools, including intraosseous infusion, pelvic stabilization, hemorrhage control and emergency airway management. With growing markets in North American, Europe and Asia, Pyng offers user-preferred medical devices for use by emergency medical services, hospital staff and military forces worldwide.

We seek Safe Harbor.